[Fundamental and clinical study of the anti-prostatic effect of allylestrenol]
- PMID: 6203385
[Fundamental and clinical study of the anti-prostatic effect of allylestrenol]
Erratum in
- Hinyokika Kiyo 1986 May;32(5):following 788
Abstract
The anti-androgen activity of allylestrenol was studied in the rat, and it was found to have an activity which was equivalent to that of chlormadinone acetate. The direct anti-prostatic activity is the result of the following mechanism: inhibition of serum testosterone uptake into the prostate, inhibition of testosterone-5 alpha-reductase activity and inhibition of 5 alpha-DHT . receptor complex formation. Large doses of allylestrenol administered to normal mature rats, inhibit the hypothalamus-pituitary-gonadal axis, and atrophy of the prostate will be more marked due to an indirect effect as a result of the reduction in the serum testosterone level. Based on this finding, we performed a clinical trial with allylestrenol in patients with hypertrophy of the prostate and cancer of the prostate. We administered 45 mg a day allylestrenol to 19 patients with prostatic hypertrophy and obtained satisfactory clinical results in so far as improvement of micturition and reduction in prostate mass was concerned. We also administered 90 mg a day of allylestrenol to 4 patients with cancer of the prostate and obtained a cytostatic effect.
Similar articles
-
[Clinical effects of allylestrenol on prostatic hypertrophy].Hinyokika Kiyo. 1986 Mar;32(3):486-92. Hinyokika Kiyo. 1986. PMID: 2425611 Japanese.
-
[Clinical effect of allylestrenol on benign prostatic hypertrophy].Hinyokika Kiyo. 1986 Mar;32(3):477-85. Hinyokika Kiyo. 1986. PMID: 2425610 Japanese.
-
Effects of steroid 5alpha-reductase inhibitor ONO-9302 and anti-androgen allylestrenol on the prostatic growth, and plasma and prostatic hormone levels in rats.Jpn J Pharmacol. 1997 Jul;74(3):243-52. doi: 10.1254/jjp.74.243. Jpn J Pharmacol. 1997. PMID: 9268084
-
5alpha-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction.Best Pract Res Clin Endocrinol Metab. 2008 Apr;22(2):389-402. doi: 10.1016/j.beem.2008.01.016. Best Pract Res Clin Endocrinol Metab. 2008. PMID: 18471794 Review.
-
[Anti-androgens. Animal experiments and clinical application].Internist (Berl). 1971 May;12(5):198-205. Internist (Berl). 1971. PMID: 4103750 Review. German. No abstract available.
Cited by
-
Oral exposure of sulpiride promotes the proliferation of Brown-Norway rat prostates.Exp Ther Med. 2020 Apr;19(4):2551-2562. doi: 10.3892/etm.2020.8521. Epub 2020 Feb 11. Exp Ther Med. 2020. PMID: 32256734 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical